Advertisement

Topics

Eisai GmbH Company Profile

21:19 EST 19th November 2017 | BioPortfolio

Auf dem globalen Pharmamarkt zählt Eisai zu den führenden forschungs-
orientierten Pharmaunternehmen.
Mit innovativen Präparaten für Erkrankungen des Zentralen Nerven-
systems sowie im Magen-Darm-Bereich hilft Eisai, die Lebensqualität von Patienten und deren Angehörigen zu verbessern. Eisai - als human health care Unternehmen weltweit aktiv und nah am Kunden.

Location

Lyoner Straße 36
Frankfurt
60528
Germany

Contact

Phone: 49 (69) 66 58 50
Fax: 49 (69) 66 58 525
Email: kontakt_wien(at)eisai.net


News Articles [261 Associated News Articles listed on BioPortfolio]

Eisai and Biotoscana Sign Exclusive Licensing Agreement for Latin America

TOKYO, Oct 4, 2017 - (JCN Newswire) - Eisai Co., Ltd. announced today that its U.S. subsidiary, Eisai Inc., has signed an exclusive licensing agreement with Grupo Biotoscana for Eisai's oncology an...

Eisai, Biotoscana ink exclusive licensing pact for Latin America

Eisai announced that its US subsidiary, Eisai, has signed an exclusive licensing agreement with Grupo Biotoscana for Eisai's oncology and neurology products in Latin America.

Ono and Eisai focus on hepatocellular carcinoma in new trial collaboration

Eisai Co. Ltd. partnered with Ono Pharmaceutical Co. Ltd. to develop a hepatocellular carcinoma therapy combining Eisai’s Lenvima (lenvatinib) with Ono’s Opdivo (nivolumab).

FDA Approves Additional Use of Antiepileptic Drug Fycompa as Monotherapy for Partial-onset Seizures

July 27, 2017 Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced that on July 26, 2017 (U.S. time), its U.S. subsidiary Eisai Inc. received approval from the U.S. Food...

Biogen and Eisai Expand Collaboration for Development of Aducanumab in Alzheimer’s Disease

CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (NASDAQ: BIIB) (Headquarters: Cambridge, Massachusetts, Un...

Eisai enters license deals for Latin America and Japan

Eisai’s US subsidiary has signed an exclusive licensing agreement with Uruguay-headquartered Grupo…

FDA Approves Second Indication for Eisai's Monotherapy, Treating Partial-Onset Seizures

NewsFDA approves Eisai's FYCOMPA® (perampanel) for use as monotherapy for the treatment of partial-onset seizures.

Biogen and Eisai expand Alzheimer’s collaboration

Japanese and US pharma majors Eisai and Biogen say they have expanded their existing agreement to jointly…

Drugs and Medications [37 Associated Drugs and Medications listed on BioPortfolio]

Alcohol prep pad [Büttner-Frank GmbH]

Halaven [Eisai Inc.]

These highlights do not include all the information needed to use HALAVEN™ safely and effectively. See full prescribing information for HALAVEN. HALAVEN™ (eribulin mesylate) Injection For intraven...

La prairie switzerland [Juvena Produits de Beaute GMBH]

Package.Label Principle Display Panel

Lusedra [Eisai, Inc]

These highlights do not include all the information needed to use LUSEDRA safely and effectively. See full prescribing information for LUSEDRA. LUSEDRA (fospropofol disodium) Injection, for intravenou...

Purax pure pads [Purax International GmbH]

PURAX Pure Pads Anti-Perspirant Spray

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)

This is a pilot trial to test perampanel (Fycompa; Eisai, Inc.) in ALS patients. The investigators will focus on safety and preliminary signs of efficacy. Perampanel is approved by the FDA...

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole sodium delayed-release 20 mg tablets to Eisai's Aciphex® delayed-release 20 mg tablets following a...

Companies [536 Associated Companies listed on BioPortfolio]

Eisai GmbH

Auf dem globalen Pharmamarkt zählt Eisai zu den führenden forschungs- orientierten Pharmaunternehmen. Mit innovativen Präparaten für Erkrankungen des Zentralen Nerven- systems sowie im Magen-Darm-...

Eisai Europe Ltd

Eisai is committed to developing and delivering highly beneficial new treatments to help improve the lives of people with epilepsy. The development of AEDs is a major strategic ar...

Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Res...

Eisai Europe Limited

Eisai is committed to making further contributions to addressing the diversified needs and improving quality of life of patients with epilepsy. Eisai has three currently marketed treatments in Eur...

Eisai Co., Ltd.

Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facili...

More Information about "Eisai GmbH" on BioPortfolio

We have published hundreds of Eisai GmbH news stories on BioPortfolio along with dozens of Eisai GmbH Clinical Trials and PubMed Articles about Eisai GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eisai GmbH Companies in our database. You can also find out about relevant Eisai GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record